Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
6.23
+0.77 (14.10%)
Nov 5, 2024, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
236326112206262
Market Cap Growth
16.54%191.65%-45.72%-21.31%-
Enterprise Value
172229193--
Last Close Price
6.239.139.9810.0812.81
PE Ratio
--6.18-4.45-0.92-1.21
PS Ratio
106.40118.2431.67-263.6045.93
PB Ratio
5.064.802.13-10.4290.02
P/FCF Ratio
-6.52-7.06-3.74-10.46-9.80
P/OCF Ratio
-6.54-7.07-3.82-10.61-10.01
EV/Sales Ratio
82.6982.9554.51--
EV/EBITDA Ratio
-3.76-4.47-5.94--
EV/EBIT Ratio
-3.74-4.45-5.90--
EV/FCF Ratio
-4.88-4.96-6.44--
Debt / Equity Ratio
0.030.020.23-0.293.25
Debt / FCF Ratio
-0.03-0.04-0.40-0.29-0.35
Asset Turnover
0.020.030.06--
Inventory Turnover
1.340.881.232.91-
Quick Ratio
4.507.824.520.902.50
Current Ratio
4.587.954.560.922.52
Return on Equity (ROE)
-83.22%-81.47%-205.21%--
Return on Assets (ROA)
-36.75%-33.75%-37.42%-52.79%-
Return on Capital (ROIC)
-49.69%-48.00%-81.16%--
Earnings Yield
-23.58%-15.05%-30.03%-11.16%-8.15%
FCF Yield
-18.97%-14.16%-26.70%-9.56%-10.20%
Buyback Yield / Dilution
-66.07%-121.67%-609.97%-4.86%-
Total Shareholder Return
-66.07%-121.67%-609.97%-4.86%-
Source: S&P Capital IQ. Standard template. Financial Sources.